JP2023520399A5 - - Google Patents

Info

Publication number
JP2023520399A5
JP2023520399A5 JP2022559585A JP2022559585A JP2023520399A5 JP 2023520399 A5 JP2023520399 A5 JP 2023520399A5 JP 2022559585 A JP2022559585 A JP 2022559585A JP 2022559585 A JP2022559585 A JP 2022559585A JP 2023520399 A5 JP2023520399 A5 JP 2023520399A5
Authority
JP
Japan
Prior art keywords
antibody
cell
targeting agent
sequence
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022559585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520399A (ja
JP7855521B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025220 external-priority patent/WO2021202770A2/en
Publication of JP2023520399A publication Critical patent/JP2023520399A/ja
Publication of JP2023520399A5 publication Critical patent/JP2023520399A5/ja
Application granted granted Critical
Publication of JP7855521B2 publication Critical patent/JP7855521B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022559585A 2020-03-31 2021-03-31 ヒト抗ｃｄ３３抗体及びその使用 Active JP7855521B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003203P 2020-03-31 2020-03-31
US63/003,203 2020-03-31
PCT/US2021/025220 WO2021202770A2 (en) 2020-03-31 2021-03-31 Human anti-cd33 antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2023520399A JP2023520399A (ja) 2023-05-17
JP2023520399A5 true JP2023520399A5 (cg-RX-API-DMAC7.html) 2024-03-28
JP7855521B2 JP7855521B2 (ja) 2026-05-08

Family

ID=

Similar Documents

Publication Publication Date Title
Hosseini et al. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: recent advances and clinical trials
JP2023519932A5 (cg-RX-API-DMAC7.html)
JP2021524244A5 (cg-RX-API-DMAC7.html)
JP2021527431A5 (cg-RX-API-DMAC7.html)
JP2025016606A5 (cg-RX-API-DMAC7.html)
HRP20201144T1 (hr) Protutijela anti-cd3 i postupci uporabe
JP2022530089A5 (cg-RX-API-DMAC7.html)
JP2025060941A5 (cg-RX-API-DMAC7.html)
JP2019146572A5 (cg-RX-API-DMAC7.html)
RU2019138337A (ru) Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии
JP2018534933A5 (cg-RX-API-DMAC7.html)
JP2016505556A5 (cg-RX-API-DMAC7.html)
JP2017534256A5 (cg-RX-API-DMAC7.html)
JP2023527609A5 (cg-RX-API-DMAC7.html)
JP2025183307A5 (cg-RX-API-DMAC7.html)
JP2018524373A5 (cg-RX-API-DMAC7.html)
JP2021510736A5 (cg-RX-API-DMAC7.html)
JP2018519263A5 (cg-RX-API-DMAC7.html)
JP2012522513A5 (cg-RX-API-DMAC7.html)
JP2022517441A (ja) Ｂｔｌａ抗体
US20250034273A1 (en) Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof
JP2016503067A5 (cg-RX-API-DMAC7.html)
JP2022530438A5 (cg-RX-API-DMAC7.html)
JP2020515577A5 (cg-RX-API-DMAC7.html)
JP2022550243A5 (cg-RX-API-DMAC7.html)